ArticleOncoTargets and therapy2020

IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.

Chen Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.